Bioactive glass compositions

US11878940B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11878940-B2
Application numberUS-202016992534-A
CountryUS
Kind codeB2
Filing dateAug 13, 2020
Priority dateAug 13, 2019
Publication dateJan 23, 2024
Grant dateJan 23, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A silicate-based glass composition includes: 50-70 wt. % SiO2, 0.01-10 wt. % P2O5, 10-30 wt. % Na2O, 0.01-10 wt. % CaO, 0.01-10 wt. % MO, and 15-30 wt. % R2O, such that MO is the sum of MgO, CaO, SrO, BeO, and BaO, and R2O is the sum of Na2O, K2O, Li2O, Rb2O, and Cs2O.

First claim

Opening claim text (preview).

What is claimed is: 1. A fiber filament comprising a silicate-based glass composition, the glass composition comprising: 50-70 wt. % SiO 2 , 0.01-10 wt. % P 2 O 5 , 10-30 wt. % Na 2 O, 0.01-10 wt. % CaO, 0.01-10 wt. % MO, and 15-30 wt. % R 2 O, wherein MO is the sum of MgO, CaO, SrO, BeO, and BaO; wherein R 2 O is the sum of Na 2 O, K 2 O, Li 2 O, Rb 2 O, and Cs 2 O, and wherein the fiber filament comprises a biopolymer coating including at least one of: polylactic acid (PLA), polyglyolic acid (PGA), co-polymers thereof (PLGA), poly D,L-lactic acid (PDLLA), poly 3-hydroxybutyrate (P(3HB)), alginate, polycaprolactone (PCL), or polyvinyl-alcohol (PVA). 2. The fiber filament of claim 1 , wherein the glass composition further comprises: 0.01-10 wt. % K 2 O, and 0.01-5 wt. % MgO. 3. The fiber filament of claim 1 , wherein the glass composition further comprises: 0-10 wt. % Al 2 O 3 , 0-10 wt. % ZnO, 0-10 wt. % B 2 O 3 , and 0-5 wt. % Li 2 O. 4. The fiber filament of claim 1 , wherein the glass composition comprises: 60-70 wt. % SiO 2 , 5-10 wt. % P 2 O 5 , 20-30 wt. % Na 2 O, 1-10 wt. % K 2 O, 1-4 wt. % MgO, and 0.01-5 wt. % CaO. 5. The fiber filament of claim 4 , wherein the glass composition further comprises: 1-6 wt. % K 2 O. 6. The fiber filament of claim 4 , wherein the glass composition is essentially free of B 2 O 3 , Al 2 O 3 , ZnO, and Li 2 O. 7. The fiber filament of claim 1 , wherein the glass composition is configured to have a viscosity of at least 100-poise (P) at temperatures in a range of 1000° C. to 1500° C., and a liquidus temperature in a range of 900° C. to 1200° C. 8. The fiber filament of claim 1 , wherein the glass composition is configured for hydroxyapatite formation within seven days of immersion in simulated body fluid (SBF). 9. The fiber filament of claim 8 , wherein the hydroxyapatite formation comprises: granular spherical crystals having at least one size dimension in a range of 0.1-10 μm. 10. The fiber filament of claim 1 , wherein a difference between a glass transition temperature (T g ) of the glass composition and an onset of crystallization temperature (T c,o ) is at least 200° C. 11. The fiber filament of claim 1 produced via a contact coating method by passing the fiber filament through a polymer-containing reservoir. 12. The fiber filament of claim 1 , having a diameter in a range of 5 μm to 25 μm. 13. A yarn comprising at least one fiber filament of claim 1 , where the yarn has at least 50 holes. 14. A textile comprising the fiber filament of claim 1 . 15. A matrix comprising the fiber filament of claim 1 , wherein: the matrix includes at least one of: a toothpaste, mouthwash, rinse, spray, ointment, salve, cream, bandage, polymer film, oral formulation, pill, capsule, or transdermal formulation. 16. The matrix of claim 15 , wherein the fiber filament is attached to the matrix or mixed therein.

Assignees

Inventors

Classifications

  • C03C3/097Primary

    containing phosphorus, niobium or tantalum · CPC title

  • for biologically-compatible glass · CPC title

  • Fibre or filament compositions (manufacture of fibres or filaments C03B37/00) · CPC title

  • Polyesters · CPC title

  • containing calcium oxide, e.g. common sheet or container glass · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11878940B2 cover?
A silicate-based glass composition includes: 50-70 wt. % SiO2, 0.01-10 wt. % P2O5, 10-30 wt. % Na2O, 0.01-10 wt. % CaO, 0.01-10 wt. % MO, and 15-30 wt. % R2O, such that MO is the sum of MgO, CaO, SrO, BeO, and BaO, and R2O is the sum of Na2O, K2O, Li2O, Rb2O, and Cs2O.
Who is the assignee on this patent?
Corning Inc
What technology area does this patent fall under?
Primary CPC classification C03C3/097. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).